-->
Chapter 1. Introduction (2025-2033)
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (2025-2033)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary (2025-2033)
3.1. Market Snapshot
Chapter 4. Market Variables and Scope (2025-2033)
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Renal Biomarkers Market (2025-2033)
5.1. COVID-19 Landscape: Renal Biomarkers Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends (2025-2033)
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape (2025-2033)
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Renal Biomarkers Market, By Biomarker (2025-2033)
8.1. Renal Biomarkers Market Revenue and Volume, by Biomarker, 2025-2033
8.1.1 Functional Biomarker
8.1.1.1. Market Revenue and Volume Forecast 2025-2033
8.1.2. Up-regulated Protein
8.1.2.1. Market Revenue and Volume Forecast 2025-2033
8.1.3. Other Biomarker
8.1.3.1. Market Revenue and Volume Forecast 2025-2033
Chapter 9. Global Renal Biomarkers Market, By Diagnostic Technique (2025-2033)
9.1. Renal Biomarkers Market Revenue and Volume, by Diagnostic Technique, 2025-2033
9.1.1. Enzyme-linked Immunosorbent Assay
9.1.1.1. Market Revenue and Volume Forecast 2025-2033
9.1.2. Colorimetric Assay
9.1.2.1. Market Revenue and Volume Forecast 2025-2033
9.1.3. Particle-enhanced Turbidimetric Immunoassay (PETIA)
9.1.3.1. Market Revenue and Volume Forecast 2025-2033
9.1.4. Chemiluminescent Enzyme Immunoassay (CLIA)
9.1.4.1. Market Revenue and Volume Forecast 2025-2033
9.1.5. Liquid Chromatography Mass
9.1.5.1. Market Revenue and Volume Forecast 2025-2033
9.1.6. Spectrometry (LC-MS)
9.1.6.1. Market Revenue and Volume Forecast 2025-2033
Chapter 10. Global Renal Biomarkers Market, By End-user (2025-2033)
10.1. Renal Biomarkers Market Revenue and Volume, by End-user, 2025-2033
10.1.1. Hospital
10.1.1.1. Market Revenue and Volume Forecast 2025-2033
10.1.2. Diagnostic Laboratory
10.1.2.1. Market Revenue and Volume Forecast 2025-2033
10.1.3. Other
10.1.3.1. Market Revenue and Volume Forecast 2025-2033
Chapter 11. Global Renal Biomarkers Market, Regional Estimates and Trend Forecast (2025-2033)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.1.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.1.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.1.4.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.1.4.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.1.5.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.1.5.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.2.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.2.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.2.4.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.2.4.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.2.5.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.2.5.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.2.6.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.2.6.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.2.7.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.2.7.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.3.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.3.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.3.4.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.3.4.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.3.5.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.3.5.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.3.6.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.3.6.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.3.7.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.3.7.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.4.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.4.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.4.4.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.4.4.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.4.5.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.4.5.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.4.6.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.4.6.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.4.7.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.4.7.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.5.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.5.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.5.4.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.5.4.3. Market Revenue and Volume Forecast, by End-user 2025-2033
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Biomarker 2025-2033
11.5.5.2. Market Revenue and Volume Forecast, by Diagnostic Technique 2025-2033
11.5.5.3. Market Revenue and Volume Forecast, by End-user 2025-2033
Chapter 12. Company Profiles (2025-2033)
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Beckman Coulter Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. BioMérieux
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. BioPorto Diagnostics AS
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. BIO-RAD LABORATORIES INC.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. F. HOFFMANN-LA ROCHE LTD.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Randox Laboratories Ltd
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. SEKISUI MEDICAL CO., LTD.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Siemens Healthineers AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Sphingotec GmbH
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. THERMO FISHER SCIENTIFIC INC.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology (2025-2033)
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix (2025-2033)
14.1. About Us
14.2. Glossary of Terms
著作権 ©2022 無断複写・転載を禁じます